Podchaser Logo
Home
 TPX 2023 Series - EP5: Safety Findings of Dosing Gene Therapy Vectors in NHP With Pre-existing or Treatment-Emergent Anti-capsid Antibodies

TPX 2023 Series - EP5: Safety Findings of Dosing Gene Therapy Vectors in NHP With Pre-existing or Treatment-Emergent Anti-capsid Antibodies

Released Tuesday, 12th March 2024
Good episode? Give it some love!
 TPX 2023 Series - EP5: Safety Findings of Dosing Gene Therapy Vectors in NHP With Pre-existing or Treatment-Emergent Anti-capsid Antibodies

TPX 2023 Series - EP5: Safety Findings of Dosing Gene Therapy Vectors in NHP With Pre-existing or Treatment-Emergent Anti-capsid Antibodies

 TPX 2023 Series - EP5: Safety Findings of Dosing Gene Therapy Vectors in NHP With Pre-existing or Treatment-Emergent Anti-capsid Antibodies

TPX 2023 Series - EP5: Safety Findings of Dosing Gene Therapy Vectors in NHP With Pre-existing or Treatment-Emergent Anti-capsid Antibodies

Tuesday, 12th March 2024
Good episode? Give it some love!
Rate Episode

Podcast Editor, Tracy Carlson, interviews authors Sundeep Chandra and Brian Long regarding their article, "Safety Findings of Dosing Gene Therapy Vectors in NHP With Pre-existing or Treatment-Emergent Anti-capsid Antibodies" which can currently be found in Volume 51, Issue 5 of Toxicologic Pathology.

Click here to read the article

Show More

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features